{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:12Z","timestamp":1786987032172,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clindermatol.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:26:46Z","timestamp":1746905206000},"page":"471-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hidradenitis suppurativa in autoinflammatory syndromes"],"prefix":"10.1016","volume":"43","author":[{"given":"Zrinka Bukvi\u0107","family":"Mokos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines Lako\u0161","family":"Juki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da\u0161ka \u0160tulhofer","family":"Buzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Vlahini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0161ko","family":"Mi\u0161e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2025.05.003_bib0001","first-page":"9","article-title":"Understanding the relationship between smoking and hidradenitis suppurativa","volume":"28","author":"Bukvi\u0107 Mokos","year":"2020","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0002","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa ?\u201415 years after","volume":"29","author":"Zouboulis","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0003","first-page":"482","article-title":"Bacterial infections of the skin","author":"Pillsbury","year":"1956","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0004","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jdv.14464","article-title":"Recognizing syndromic hidradenitis suppurativa: a review of the literature","volume":"31","author":"Gasparic","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clindermatol.2020.10.016","article-title":"PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa","volume":"39","author":"Garcovich","year":"2021","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0006","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3389\/fimmu.2020.01753","article-title":"Editorial: Autoinflammatory keratinization disease (AiKD)","volume":"11","author":"Akiyama","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0007","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0008","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0009","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jmb.2017.12.005","article-title":"Mechanisms and consequences of inflammasome activation","volume":"430","author":"Schroder","year":"2018","journal-title":"J Mol Bio"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0012","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3389\/fimmu.2020.01177","article-title":"Editorial: Autoinflammatory diseases: from genes to bedside","volume":"11","author":"Aksentijevich","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"French FMF Consortium","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0014","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jid.2017.04.024","article-title":"Hidradenitis suppurativa is associated with familial Mediterranean fever - a population-based study","volume":"137","author":"Hodak","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00439-002-0860-x","article-title":"Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P","volume":"112","author":"Hoffman","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0016","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control study","volume":"180","author":"Vural","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ni.2222","article-title":"Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1\u03b2 via a noncanonical caspase-8 inflammasome","volume":"13","author":"Gringhuis","year":"2012","journal-title":"Nature Immunol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.immuni.2012.01.012","article-title":"Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation","volume":"36","author":"Vince","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0019","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1159\/000509873","article-title":"Phenotypes and pathophysiology of syndromic hidradenitis suppurativa: different faces of the same disease? A systematic review","volume":"237","author":"Nikolakis","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archdermatol.2010.328","article-title":"Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review","volume":"146","author":"Hsiao","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0021","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-97-4-520","article-title":"Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata","volume":"97","author":"Rosner","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0022","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3899\/jrheum.130977","article-title":"Hidradenitis suppurativa associated with spondyloarthritis- results from a multicenter national prospective study","volume":"41","author":"Richette","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2133.2009.09430.x","article-title":"Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study","volume":"162","author":"van der Zee","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0024","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.3748\/wjg.v22.i20.4802","article-title":"Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association","volume":"22","author":"Principi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","article-title":"Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional study","volume":"76","author":"Deckers","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/194864","article-title":"Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives","volume":"2015","author":"Lopalco","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00251-020-01158-6","article-title":"Differential expression of the inflammasome complex genes in systemic lupus erythematosus","volume":"72","author":"da Cruz","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2503378","article-title":"Interleukin-1 links autoimmune and autoinflammatory pathophysiology in mixed-pattern psoriasis","volume":"2021","author":"K\u00f6lliker Frers","year":"2021","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0029","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.12688\/f1000research.21216.1","article-title":"Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches","volume":"8","author":"Tampouratzi","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13089","article-title":"One drug and two diseases: a case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast","volume":"32","author":"Lanna","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09546634.2019.1654067","article-title":"Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn\u2019s disease","volume":"32","author":"Berman","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0032","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0033","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0034","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) - a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjd.13668","article-title":"First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome","volume":"173","author":"Duchatelet","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0036","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/bjd.14383","article-title":"PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome","volume":"175","author":"Calder\u00f3n-Castrat","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0037","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1111\/1346-8138.14259","article-title":"Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome","volume":"45","author":"Saito","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0038","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/bjd.15740","article-title":"PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity","volume":"178","author":"Sonbol","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0039","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjd.18003","article-title":"PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens","volume":"181","author":"Gottlieb","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ajpath.2010.12.053","article-title":"Spontaneous insertion of a B2 element in the Ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0041","article-title":"Pyoderma gangrenosum, acne, and hidradenitis suppurativa syndrome: a case report and literature review","volume":"9","author":"Huang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0042","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ijd.13603","article-title":"Autoinflammatory syndromes associated with hidradenitis suppurativa and\/or acne","volume":"56","author":"Vinkel","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0043","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","article-title":"Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases","volume":"93","author":"Marzano","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0044","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.14691","article-title":"Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation","volume":"175","author":"Marzano","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jdcr.2016.11.006","article-title":"Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis","volume":"3","author":"Niv","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0046","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1159\/000521263","article-title":"Whole-exome sequencing in 10 unrelated patients with syndromic hidradenitis suppurativa: a preliminary step for a genotype-phenotype correlation","volume":"238","author":"Marzano","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0047","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","article-title":"Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor \u03b1 therapy","volume":"18","author":"Bruzzese","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0048","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0049","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","article-title":"PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition","volume":"72","author":"Saraceno","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/24725625.2021.1881216","article-title":"A case of myeloperoxidase-antineutrophil cytoplasmic antibody and anticardiolipin antibody-positive pyogenic arthritis, pyoderma gangrenosum, acne and hidradenitis suppurativa (PAPASH) syndrome with colitis","volume":"5","author":"Kawanishi","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0051","doi-asserted-by":"crossref","first-page":"587","DOI":"10.12659\/AJCR.898027","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PA-PASH) syndrome: an atypical presentation of a rare syndrome","volume":"17","author":"Ursani","year":"2016","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0052","first-page":"187","article-title":"Le syndrome acn\u00e9 pustulose hyperostose ost\u00e9ite (SAPHO). R\u00e9sultats d'une enqu\u00eate nationale. 85 observations [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]","volume":"54","author":"Chamot","year":"1987","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0053","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0049-0172(99)80027-4","article-title":"SAPHO syndrome: a long-term follow-up study of 120 cases","volume":"29","author":"Hayem","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0054","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.semarthrit.2012.05.006","article-title":"The SAPHO syndrome","volume":"42","author":"Nguyen","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.crad.2011.08.014","article-title":"SAPHO: what radiologists should know","volume":"67","author":"Depasquale","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0056","first-page":"109","article-title":"Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?","volume":"6","author":"Benhamou","year":"1988","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0057","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3899\/jrheum.171007","article-title":"Is SAPHO syndrome linked to PASH syndrome and hidradenitis suppurativa by nicastrin mutation? A case report","volume":"45","author":"Li","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.861241","article-title":"The genomic architecture of hidradenitis suppurativa-a systematic review","volume":"13","author":"Pace","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0059","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0060","first-page":"444","article-title":"Biologics for rare inflammatory diseases: TNF blockade in the SA PHO syndrome","volume":"70","author":"Burgemeister","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0061","first-page":"185","article-title":"SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate","volume":"69","author":"De Souza","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0062","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.15233","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0063","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0064","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0065","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.clindermatol.2025.05.003_bib0066","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jaad.2015.07.040","article-title":"Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients","volume":"73","author":"Join-Lambert","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0067","first-page":"17","article-title":"Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome","volume":"4","author":"Lamiaux","year":"2017"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0068","first-page":"1192","article-title":"Adalimumab treatment in women with moderate-to-severe hidradenitis suppurativa from the placebo-controlled portion of a phase 2, randomized, double-blind study","volume":"15","author":"Gottlieb","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"suppl 6","key":"10.1016\/j.clindermatol.2025.05.003_bib0069","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jdv.15849","article-title":"Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate","volume":"33","author":"Genovese","year":"2019","journal-title":"J Eur Acad Dermatol. Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ijd.13740","article-title":"SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature","volume":"57","author":"Vekic","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0071","article-title":"Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections","volume":"6","author":"Crowley","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0072","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.semarthrit.2018.04.003","article-title":"Biologics in SAPHO syndrome: a systematic review","volume":"48","author":"Daoussis","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2025.05.003_bib0073","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/exd.14338","article-title":"Target molecules for future hidradenitis suppurativa treatment","volume":"30","author":"Zouboulis","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0074","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/ced.14333","article-title":"MABp1 targeting interleukin-1\u03b1 in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period","volume":"46","author":"Kanni","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.10.024","article-title":"A phase II open-label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain","volume":"140","author":"Gottlieb","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0077","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jdv.12631","article-title":"Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?","volume":"30","author":"Garzorz","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0078","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bjd.13292","article-title":"Two cases of severe hidradenitis suppurativa with failure of anakinra therapy","volume":"172","author":"Menis","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0079","doi-asserted-by":"crossref","first-page":"381","DOI":"10.12688\/f1000research.52100.2","article-title":"Case report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab","volume":"10","author":"Nikolakis","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0080","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2012-202392","article-title":"Successful long-term triple disease control by ustekinumab in a patient with Behcet\u2019s disease, psoriasis and hidradenitis suppurativa","volume":"72","author":"Baerveldt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0081","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jaad.2020.02.005","article-title":"Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: results of an open-label trial","volume":"82","author":"Casseres","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0082","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1111\/jdv.17178","article-title":"Effectiveness of secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting","volume":"35","author":"Ribero","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0083","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/jdv.13727","article-title":"Systematic review of surgical treatment of pyoderma gangrenosum with negative pressure wound therapy or skin grafting","volume":"31","author":"Pichler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0084","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/iwj.13403","article-title":"Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome","volume":"17","author":"Zagaria","year":"2020","journal-title":"Int Wound J"},{"key":"10.1016\/j.clindermatol.2025.05.003_bib0085","first-page":"216","article-title":"Is PASH syndrome a biofilm disease?: a case series and review of the literature","volume":"30","author":"Ead","year":"2018","journal-title":"Wounds"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:40:50Z","timestamp":1753234850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X25001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0738081X25001452"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.05.003","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis suppurativa in autoinflammatory syndromes","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}